Trials / Conditions / EGFR-TKI Sensitizing Mutation
EGFR-TKI Sensitizing Mutation
4 registered clinical trials studyying EGFR-TKI Sensitizing Mutation — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With NCT07298148 | Peking University Cancer Hospital & Institute | Phase 2 |
| Completed | First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer NCT06521034 | Yongchang Zhang | Phase 1 / Phase 2 |
| Unknown | Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) NCT02661009 | GenoSaber | — |
| Recruiting | A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment NCT01994057 | Sun Yat-sen University | — |